FUMIYUKI YAMASAKI

Last Updated :2020/12/01

Affiliations, Positions
Hiroshima University Hospital, Associate Professor or Lecturer
Web Site
E-mail
fyamahiroshima-u.ac.jp
Other Contact Details
1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
TEL : (+81)82-257-5227 FAX : (+81)82-257-5229
Self-introduction
Fumiyuki Yamasaki was born in Okayama, Japan in 1969. He completed his Clinical Residency in Neurosurgery at Kure National Hospital, Kure, Japan in 1996. He received the the Ph.D. degree from the Hiroshima University, Hiroshima, Prefecture, Japan in 2003. From 2003 to 2006, he was a Research Fellow at MD Anderson Cancer Center, the University of Texas, Houston, Texas. F. Yamasaki is currently an Associate Professor in the Department of Neurosurgery, at the Hiroshima University, Hiroshima, Japan. He is skilled in surgical neuro-oncology, neuro-oncology and pediatric neuro-oncology. He is also skilled in diagnostic neuroradiology including MRI, PET/CT, and functional/advanced imaging.

Basic Information

Educational Backgrounds

  • Hiroshima University, Graduate School, Division of Medical Sciences, Surgical Neuro-oncology, Japan, 1999/04, 2003/03
  • Hiroshima University, Faculty of Medicine, Medical, Japan, 1987/04, 1993/03

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • 【Bachelor Degree Program】School of Medicine : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Neurosurgery

Research Keywords

  • brain tumor
  • pediatric brain tumor
  • malignant brain tumor
  • Neuro-oncoloty
  • Neuro-Radiology
  • Molecular target therapy
  • microRNA
  • Radiogenomics

Affiliated Academic Societies

  • International Society for Magnetic Resonance in Medicine (ISMRM), 2016/10
  • American Association for Cancer Research (AACR)
  • Society for Neuro-oncology (SNO)
  • The Japan Neurosurgical Society
  • The Japanese Congress of Neurological Surgeons
  • Japanese Cancer Association
  • Japan Society of Clinical Oncology
  • Japanese Society of Medical Oncology, 2012/04
  • The Japan Society for Neuro-oncology
  • The Japan Society of Brain Tumor Pathology
  • The Japanese Society for Hypothalamic and Pituitary Tumors, 2013/02
  • Japanese Society for Pediatric Neurosurgery
  • The Japanese Society of Pediatric Hematology/ Oncology, 2011/06
  • Japanese Society for Magnetic Resonance in Medicine
  • The Japanese Society of Neuroradiology
  • Japan Society for CNS Computed Imaging
  • The Japan Stroke Society
  • Japan Awake Surgery conference
  • The Japanese Congress for Brain Tumor Surgery
  • AYA Oncology Alliance, 2018/09
  • Japan Society for Medical Education, 2019/03
  • The Japan Society of Neurotraumatology

Educational Activity

Course in Charge

  1. 2020, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2020, Undergraduate Education, 2Term, Surgery II

Research Activities

Academic Papers

  1. A Case of Ninety-six-year-old Woman with an Acute Subdural Hematoma., Japanese Journal of National Medical Services, 48(12), 1079-1082, 1994
  2. A case of dural arteriovenous malformation in the anterior fossa associated with an occlusion of the unilateral middle cerebral artery with moyamoya phenomenon., No Shinkei Geka, 23(7), 603-607, 199507
  3. Choroid Plexus Carcinoma in the Lateral Ventricle : Case Report, 神経外科, 35(10), 742-744, 19951015
  4. A case of cranial hypertrophic pachymeningitis with intracranial hemorrhage, No To Shinkei, 48(5), 475-480, 199605
  5. Paget's Disease complicated by an Intracerebral Hemorrhage : A Case Report, Japanese journal of neurosurgery, 5(6), 465-469, 19961120
  6. Adult-onset aqueductal stenosis caused by membranous occlusion in the aqueduct: a case report., No Shinkei Geka, 24(8), 745-748, 199608
  7. A study of stereotactic rotatory irradiation for metastatic brain tumors., Japanese Journal of National Medical Services, 50(1), 27-31, 1996
  8. Pure motor monoparesis due to brain contusion. A case report., Neurological Medicine, 47(5), 505-508, 199705
  9. A case of chordoid meningioma., No Shinkei Geka, 27(10), 947-951, 199910
  10. ★, Recurrence of meningiomas - Influence of vascular endothelial growth factor expression, CANCER, 89(5), 1102-1110, 200009
  11. Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning., Brain Tumor Pathol., 18(2), 61-67, 200102
  12. Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients., Anticancer Research, 20(3B), 1897-1900, 200005
  13. A case of convexity meningioma en plaque., No Shinkei Geka, 29(2), 145-150, 200102
  14. Intrasellar rhabdomyosarcoma: Case report, NEUROSURGERY, 48(3), 677-680, 200103
  15. A Case of Juvenile Pilocytic Astrocytoma with Unusual Neuroimaging Features, 53(4), 391-395, 200104
  16. A Case of a Vertebral Dissecting Aneurysm initially Manifesting as Ischemic Stroke and Secondary Subarachnoid Hemorrhage, Japanese journal of neurosurgery, 10(10), 682-687, 20011020
  17. A Retrospective Clinical Evaluation of Brainstem Gliomas, Japanese journal of neurosurgery, 10(12), 783-788, 20011220
  18. Symptomatic subependymoma of the lateral ventricle in a young female., No To Shinkei, 53(12), 1123-1127, 200112
  19. Detection of a pineoblastoma with large central cyst in a young child, CHILDS NERVOUS SYSTEM, 18(3-4), 157-160, 200204
  20. Myelodysplastic Syndrome Following Therapy for Brain Tumor, 神経外科, 42(4), 170-174, 20020415
  21. Good clinical course in infants with desmoplastic cerebral neuroepithelial tumor treated by surgery alone, JOURNAL OF NEURO-ONCOLOGY, 59(1), 63-69, 200208
  22. Interhemispheric arachnoid cyst in the elderly: Case report and review of the literature, SURGICAL NEUROLOGY, 59(1), 68-74, 200301
  23. Expression of survivin in astrocytic tumors - Correlation with malignant grade and prognosis, CANCER, 97(4), 1077-1083, 200302
  24. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at GI in U251MG human glioma cell line, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 51(4), 271-283, 200304
  25. Staurosporine-induced aoootosis is independent of p16 and p21 and achieved via arrest at G2/M and at Gnn U251MG human alioma cell line, Medical journal of Hiroshima University, 51(2), 20030428
  26. Contrast Enhanced Fast Fluid-Attenuated Inversion-recovery MR Imaging for Diagnosing Cerebral Venous Angioma : Report of Two Cases, 55(6), 537-541, 200306
  27. p16 gene transfer increases cell killing with abnormal nucleation after ionizing radiation in glioma cells, Br J Cancer, 89(9), 1802-1811, 200311
  28. Image box, third ventricle tumors., Innervision, Show, 18(8), 15-16, 2003
  29. Relationship between Intratumoral Hemorrhage and Overexpression of Vascular Endothelial Growth Factor (VEGF) in Pituitary Adenoma, Hiroshima journal of medical sciences, 53(2), 23-27, 200406
  30. ★, Apparent diffusion coefficient of human brain tumors at MR imaging, RADIOLOGY, 235(3), 985-991, 200506
  31. Cyclin A-associated kinase activity is needed for paclitaxel sensitivity., Mol Cancer Ther, 4(7), 1039-1046, 200507
  32. ★, Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy, NEUROSURGICAL REVIEW, 28(4), 267-277, 200510
  33. Prognosis of cerebellar glioblastomas: Correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas, ANTICANCER RESEARCH, 26(2B), 1351-1357, 2006
  34. Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells., Cancer Gene Ther, 13(5), 451-459, 200605
  35. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas, Journal of Neurooncology, 77(3), 273-277, 200605
  36. A pituitary abscess showing high signal intensity on diffusion-weighted imaging, NEUROSURGICAL REVIEW, 29(3), 246-248, 200607
  37. Retinoblastoma protein prevents staurosporine-induced cell death in a retinoblastoma-defective human glioma cell line, PATHOBIOLOGY, 74(1), 22-31, 200701
  38. Geminin: A good prognostic factor in high-grade astrocytic brain tumors, CANCER, 109(5), 949-956, 200703
  39. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker, JOURNAL OF NEURO-ONCOLOGY, 82(2), 193-198, 2007
  40. ★, Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt, CANCER RESEARCH, 67(12), 5779-5788, 200706
  41. Pineal Tumor with Extremely High Serum-titer of Human Chorionic Gonadotropin(NEUROIMAGING and NEUROPATHOLOGY of BRAIN TUMORS), Japanese journal of neurosurgery, 16(7), 578-582, 20070720
  42. Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity, MOLECULAR CANCER THERAPEUTICS, 6(8), 2168-2177, 200708
  43. Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease, NEUROSURGICAL REVIEW, 31(1), 77-81, 200801
  44. Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells, BRITISH JOURNAL OF CANCER, 98(2), 345-355, 200801
  45. Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells., Mol Cancer Ther, 7(7), 1846-1850, 200807
  46. Secondary anaplastic oligodendroglioma after cranial irradiation: a case report, Journal of Neuro-Oncology, 88(3), 299-303, 200807
  47. Familial occurrence of dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: Case report, NEUROSURGERY, 63(2), 370-372, 200808
  48. PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival., Cancer Res., 68(22), 9302-9310, 200811
  49. Efficacy of Fusion CTA for Following Aneurysms Treated by Coil Embolization, 30(1), 29-34, 20080630
  50. CENTROSOME AMPLIFICATION INDUCED BY SURVIVIN SUPPRESSION ENHANCES BOTH CHROMOSOME INSTABILITY AND RADIOSENSITIVITY IN GLIOMA CELLS, NEURO-ONCOLOGY, 11(2), 220-220, 2009
  51. Advantages of High b Value Diffusion-Weighted Imaging in the Diagnosis of Acute Stroke - A Case Report, CEREBROVASCULAR DISEASES, 27(6), 616-617, 2009
  52. Quality of Life of Extremely Long-Time Germinoma Survivors Mainly Treated with Radiotherapy., Prog Neurol Surg., 23, 130-139, 200903
  53. Diagnosis of Intracranial Lesion by Single Voxel Proton MR Spectroscopy, Japanese journal of neurosurgery, 18(8), 603-608, 20090820
  54. The Combination of Low Cytoplasmic and High Nuclear Expression of p27 Predicts a Better Prognosis in High-grade Astrocytoma, ANTICANCER RESEARCH, 29(2), 597-603, 2009
  55. Recent advancement of MR imaging in neuroradiology, The journal of the Hiroshima Medical Association, 62(10), 504-512, 2009
  56. Third Ventricular Tumor in a 5-year-old Girl(NEUROIMAGING and NEUROPATHOLOGY of BRAIN TUMORS), Japanese journal of neurosurgery, 19(1), 66-71, 20100120
  57. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase., Clin Cancer Res., 16(6), 1802-1811, 201003
  58. Cerebral Angiography using Gadolinium as an Alternative Contrast Medium in a Patient with Severe Allergy to Iodinated Contrast Medium, Hiroshima Journal of Medical Sciences, 59(1), 15-16, 201003
  59. Glioblastoma treated with postoperative radio-chemotherapy : Prognostic value of apparent diffusion coefficient at MR imaging, European Journal of Radiology, 73(3), 532-537, 201003
  60. Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions, EUROPEAN JOURNAL OF RADIOLOGY, 74(3), 420-427, 201006
  61. Tumor-markers in CNS germ cell tumors, Japanese journal of clinical medicine, 68(0), 292-297, 201012
  62. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis, Journal of Neuro-Oncology, 100(3), 449-457, 201012
  63. Twelve Clinically Significant Points in Medulloblastoma(Pediatric Neurosurgery and Long-term Prognosis), Japanese journal of neurosurgery, 20(5), 363-371, 20110520
  64. ★, Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma, NEURO-ONCOLOGY, 13(7), 791-801, 201107
  65. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas, EUROPEAN JOURNAL OF RADIOLOGY, 80(2), 412-417, 201111
  66. Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt, JOURNAL OF CANCER, 2, 435-442, 2011
  67. A Case of Central Nervous System Lymphomatoid Granulomatosis Successfully Treated With Corticosteroids, 64(1), 85-87, 201201
  68. Lymphomas and glioblastomas: Differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 T, EUROPEAN JOURNAL OF RADIOLOGY, 81(2), 339-344, 201202
  69. A survey of pediatricians' and neurosurgeons' policies regarding the use of corticosteroids in children with cancer and brain tumors., No Shinkei Geka, 40(7), 607-616, 201207
  70. Expression of phosphoprotein enriched in astrocytes 15kDa (PEA-15) in astrocytic tumors, 65(2), 78-83, 201202
  71. Role of perfusion-weighted imaging at 3 T in the histopathological differentiation between astrocytic and oligodendroglial tumors, EUROPEAN JOURNAL OF RADIOLOGY, 81(8), 1863-1869, 201208
  72. Evaluation of cerebellar mutism by arterial spin-labeling perfusion magnetic resonance imaging in a patient with atypical teratoid/rhabdoid tumor (AT/RT): a case report, CHILDS NERVOUS SYSTEM, 28(8), 1257-1260, 201208
  73. MAGNETIC RESONANCE SPECTROSCOPIC DETECTION OF LACTATE IS PREDICTIVE OF A POOR PROGNOSIS IN PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMA, NEURO-ONCOLOGY, 14, 141-141, 2012
  74. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment, EUROPEAN JOURNAL OF RADIOLOGY, 81(10), 2805-2810, 201210
  75. Bilateral Diffuse Hypoperfusion of Cerebrum in a Patient with Cerebellar Mutism : A Case Report, 64(12), 1431-1433, 201212
  76. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma, 66(2), 61-67, 201302
  77. Preoperative histological grading of meningiomas using apparent diffusion coefficient at 3T MRI, EUROPEAN JOURNAL OF RADIOLOGY, 82(4), 658-663, 201304
  78. Desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia., INTERNATIONAL CANCER CONFERENCE JOURNAL, 2(3), 178-182, 201307
  79. Availability of intraoperative MRI in brain tumor surgery : From the view point of new introduction, 66(10), 567-572, 201310
  80. Transorbital penetrating intracranial injury by a chopstick: a case report and review of the literature., Neurological Surgery, 41(11), 1001-1009, 201311
  81. A Case of Papillary Glioneuronal Tumor, Jpn J Neurosurg, 22(11), 860-865, 20131120
  82. Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy, No Shinkei Geka, 42(1), 27-34, 201401
  83. Neuroimaging diagnosis of pineal region tumors-quest for pathognomonic finding of germinoma, NEURORADIOLOGY, 56(7), 525-534, 201407
  84. QUALITY OF LIFE OF EXTREMELY LONG-TIME SURVIVORS WITH GERMINOMA MAINLY TREATED WITH RADIOTHERAPY, NEURO-ONCOLOGY, 16, 2014
  85. A Multicenter Phase I/II Study of the BCNU Implant (Gliadel® Wafer) for Japanese Patients with Malignant Gliomas, Neurol. Med. Chir.(Tokyo), 54(4), 290-301, 2014
  86. p16 Gene Transfer Induces Centrosome Amplification and Abnormal Nucleation Associated with Survivin Downregulation in Glioma Cells, PATHOBIOLOGY, 82(1), 1-8, 201502
  87. ★, Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma, JOURNAL OF NEUROSURGERY, 122(6), 1370-1379, 201506
  88. The postirradiation incidence of cavernous angioma is higher in patients with childhood pineoblastoma or primitive neuroectodermal tumors than medulloblastoma, CHILDS NERVOUS SYSTEM, 31(6), 901-907, 201506
  89. Results of sequential chemoradiotherapy for intracranial germinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(6), 336-343, 201506
  90. Post-traumatic Unilateral Avulsion of the Abducens Nerve with Damage to Cranial Nerves VII and VIII - Case report, NEUROLOGIA MEDICO-CHIRURGICA, 3, 81-83, 20160516
  91. Benign fibrous histiocytoma arising at the temporal bone of an infant-case report and review of the literature, CHILDS NERVOUS SYSTEM, 32(1), 189-193, 201601
  92. Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia, CHILDS NERVOUS SYSTEM, 32(2), 395-398, 201602
  93. Diffusion-weighted imaging and the apparent diffusion coefficient on 3T MR imaging in the differentiation of craniopharyngiomas and germ cell tumors, NEUROSURGICAL REVIEW, 39(2), 207-213, 201604
  94. Solitary Langerhans cell histiocytosis located in the neurohypophysis with a positive titer HCG-beta in the cerebrospinal fluid, CHILDS NERVOUS SYSTEM, 32(5), 901-904, 201605
  95. Advantage of high b value diffusion-weighted imaging for differentiation of hemangioblastoma from brain metastases in posterior fossa., World Neurosurgery, 20170204
  96. Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma, PATHOBIOLOGY, 84(2), 99-107, 201702
  97. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide, WORLD NEUROSURGERY, 97, 21-26, 201701
  98. Transsphenoidal Posterior Pituitary Lobe Biopsy in Patients with Neurohypophysial Lesions, WORLD NEUROSURGERY, 99, 543-547, 201703
  99. Advantage of High b Value Diffusion-Weighted Imaging for Differentiation of Hemangioblastoma from Brain Metastases in Posterior Fossa, WORLD NEUROSURGERY, 101, 643-650, 201705
  100. The usefulness of high b-value diffusion-weighted MR imaging for the diagnosis of extrapontine myelinolysis - a case report, Japanese Journal of Clinical Radiology, 60(5), 712-713, 20150501
  101. Development of cystic malacia after high-dose cranial irradiation of pediatric CNS tumors in long-term follow-up, CHILDS NERVOUS SYSTEM, 33(6), 957-964, 201706
  102. Diffuse leptomeningeal glioneuronal tumor (DLGNT) mimicking Whipple's disease: a case report and literature review, CHILDS NERVOUS SYSTEM, 33(8), 1411-1414, 201708
  103. High Expression of Glypican-1 Predicts Dissemination and Poor Prognosis in Glioblastomas, WORLD NEUROSURGERY, 105, 282-288, 201709
  104. Role for loss of nuclear PTEN in a harbinger of brain metastases, JOURNAL OF CLINICAL NEUROSCIENCE, 44, 148-154, 201710
  105. Review of Current Evidence Regarding Surgery in Elderly Patients with Meningioma, NEUROLOGIA MEDICO-CHIRURGICA, 57(10), 521-533, 201710
  106. Pitfalls of Neuroendoscopic Biopsy of Intraventricular Germ Cell Tumors, WORLD NEUROSURGERY, 106, 430-434, 201710
  107. ★, Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator, JOURNAL OF NEUROSURGERY, 128(3), 667-678, 201803
  108. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide, JOURNAL OF NEUROSURGERY, 128(3), 679-684, 201803
  109. Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients, NEUROSURGICAL REVIEW, 41(2), 621-628, 201804
  110. Advantages of high b-value diffusion-weighted imaging for preoperative differential diagnosis between embryonal and ependymal tumors at 3 T MRI, EUROPEAN JOURNAL OF RADIOLOGY, 101, 136-143, 201804
  111. RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging., Brain Tumor Pathol, 35(1), 41-45, 201801
  112. ★, Proton Magnetic Resonance Spectroscopy Detection of High Lipid Levels and Low Apparent Diffusion Coefficient Is Characteristic of Germinomas., World Neurosurg, 112, e84-e94, 201804
  113. JCOG0911 INTEGRA study: a randomized screening phase II trial of interferon beta plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma., J Neurooncol, 201803
  114. Proton Magnetic Resonance Spectroscopy Detection of High Lipid Levels and Low Apparent Diffusion Coefficient Is Characteristic of Germinomas, WORLD NEUROSURGERY, 112, E84-E94, 201804
  115. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT, MEDICINE, 97(32), 201808
  116. Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis, WORLD NEUROSURGERY, 119, E890-E897, 201811
  117. Transient spontaneous regression of brainstem glioblastoma., J Neurosurg Sci, 62(5), 610-612, 20181001
  118. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma., Neuro Oncol, 20181130
  119. Abscess formation in metastatic brain tumor with history of immune checkpoint inhibitor: a case report., NMC Case Rep J., 6(1), 11-15, 20181218
  120. Microvascular decompression in patients aged 30 years or younger, Asian Journal of Neurosurgery, 14(1), 111-117, 20190221
  121. Physiologic pituitary hyperplasia causing visual disturbance during adolescence, JOURNAL OF CLINICAL NEUROSCIENCE, 61, 279-281, 201903
  122. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma, NEURO-ONCOLOGY, 21(3), 348-359, 201903
  123. Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the "Target Sign", INTERNAL MEDICINE, 58(8), 1157-1162, 20190801
  124. Comparative Evaluation of Angioscopy and Intravascular Ultrasound for Assessing Plaque Protrusion During Carotid Artery Stenting Procedures, WORLD NEUROSURGERY, 125, E448-E455, 201905
  125. Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival, PATHOBIOLOGY, 86(2-3), 152-161, 20190601
  126. Weekly vinblastine in pediatric optic pathway/hypothalamic glioma: 2 case report, No Shinkei Geka, 47(9), 977-984, 20190901
  127. ★, Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions, WORLD NEUROSURGERY, 131, E226-E236, 201911
  128. Focal hyperperfusion and elevated lactate in the cerebral lesions with anti-GABAaR encephalitis: a serial MRI study  , Journal of Neuroradiology, in press
  129. Current status of adjuvant therapy for glioblastoma and potential novel therapies, Japanese Journal of Neurosurgery, 29(3), 188-197, 20200301
  130. Long term outcome and prognostic factors for the primary central nervous system germ cell tumors, Nervous System in Children, in press
  131. Utility of dual-energy CT for predicting the vascularity of meningiomas, EUROPEAN JOURNAL OF RADIOLOGY, 123, 202002
  132. Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature, WORLD NEUROSURGERY, 134, E360-E371, 202002
  133. Advantage of high b value diffusion-weighted imaging for differentiation of common pediatric brain tumors in posterior fossa, European Journal of Radiology, in press, 2020
  134. T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor, EUROPEAN JOURNAL OF RADIOLOGY, 126, 202005
  135. Bevacizumab for optic pathway glioma with worsening visual field in absence of imaging progression: 2 case reports and literature review, CHILDS NERVOUS SYSTEM, 36(3), 635-639, 202003
  136. Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone, JOURNAL OF NEURO-ONCOLOGY, 148(1), 17-27, 202005
  137. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors, Scientific Reports, PMID: 32868820(PMID: 32868820)
  138. Radiological and immunostaining characteristics of H3.3G34R-mutant glioma: a report of three cases and review of the literature, Pediatric Neurosurgery, in press
  139. Radiology Profile as a Potential Instrument to Differentiate Between Posterior Fossa Ependymoma (PF-EPN) Group A and B, WORLD NEUROSURGERY, 140, E320-E327, 202008
  140. Imaging diagnostic algorithm for differentiation of pediatric posterior fossa brain tumors, The Japanese Journal of Pediatric Hematology/Oncology, 57(3), 203-209, 20201112
  141. A chronic encapsulated expanding hematoma that developed 15 years after gamma-knife surgery for a cerebral arteriovenous malformation: a case report and review of the literature, Neurocirugia, in press
  142. ★, The role of neurosurgeons for brain tumor survivors, Japanese Journal of Neurosurgery, in press
  143. Clinical characteristics and thyroid hormone dynamics of thyrotropin-secreting pituitary adenomas at a single institution, Endocrine, in press
  144. ★, T2-FLAIR mismatch sign and response to radiotherapy in diffuse intrinsic pontine glioma, Pediatric Neurosurgery, in press

Publications such as books

  1. 2010/10, Methods of Cancer Diagnosis, Therapy, and Prognosis: Brain Cancer., Brain tumors: Apparent diffusion coefficient at magnetic resonance imaging., Springer, 2010, 10, Textbook, Compilation, English, Yamasaki F, Sugiyama K, Kurisu K, pp279-296

Invited Lecture, Oral Presentation, Poster Presentation

  1. Recurrence of meningiomas--influence of vascular endothelial growth factor expression., Yamasaki F, Yoshioka H, Hama S, Hanaya R, Sugiyama K, Arita K, Kurisu K., Neuroscience 2000, 2000/11/05, Without Invitation, English, Society for Neuroscience, New Orleans (U.S.A.)
  2. Staurosporine induced apoptosis are not only from G2/M phase but also from G1 phase in glioma cell lines by using adenovirus-mediated p16 or p21-gene transfer., Yamasaki F, Hama S, Yoshioka H, Kajiwara Y, Hanaya R, Sugiyama K, Arita K, Kurisu K., Neuroscience 2002, 2002/11/05, Without Invitation, English, Society for Neuroscience, Orlando (U.S.A.)
  3. Sensitivity to Erlotinib (Tarceva) Depends on Cyclin-Dependent Kinase 2 Activity., Fumiyuki Yamasaki, Gabriel N. Hortobagyi, Kaoru Kurisu, Naoto T. Ueno, 96th annual meeting of American Association for Cancer Research, 2005/04/17, Without Invitation, English, AACR, Anaheim (U.S.A.)
  4. Testis-related gene, MORC1, induces dysfunctional spindle assembly checkpoint, modulating paclitaxel resistance, Fumiyuki Yamasaki, Norimitsu Inoue, Tamotsu Sudo, Dongwei Zhang, Chandra Bartholomeusz, Kaoru Kurisu, Gabriel N. Hortobagyi, Naoto T. Ueno., 97th Annual meeting of American Association for Cancer Research, 2007/04/14, Without Invitation, Japanese, American Association for Cancer Research, Los Angels (U.S.A.)
  5. Diffusion weighted imaging and apparent diffusion coefficient of intracranial abscesses at MR imaging., Fumiyuki Yamasaki, Omar M Mahmoud, Yoshinori Kajiwara, Taiichi Saito, Toshikazu Hidaka, Yuuji Akiyama, Nobukazu Abe, Ryosuke Hanaya, Kazuhiko Sugiyama, Kaoru Kurisu, ASNR 45th Annual Meeting & The Foundation of the ASNR Symposium, 2007/06/11, Without Invitation, English, ASNR, Chicago (U.S.A.)
  6. Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging., Fumiyuki Yamasaki, Kazuhiko Sugiyama, Megu Ohtaki, Taiichi Saito, Omar Mostafa Mahmoud , Nobukazu Abe, Yuji Akiyama, Ryosuke Hanaya, Kaoru Kurisu, 5th Asian Society for Neuro-Oncology, 2007/11/02, Without Invitation, English, ASNO, Istanbul (Turkey)
  7. Glioblastoma Treated with Postoperative Radio-Chemotherapy: Prognostic Value of Apparent Diffusion Coefficient at MR Imaging., Fumiyuki Yamasaki, Kazuhiko Sugiyama, Megu Ohtaki, Taiichi Saito, Toshikazu Hidaka, Omar Mostafa Mahmoud, Nobukazu Abe, Yuji Akiyama, Yoshinori Kajiwara, Ryosuke Hanaya, Kaoru Kurisu, ASNR 46th Annual Meeting & The Foundation of the ASNR Symposium, 2008/06/03, Without Invitation, English, ASNR, New Orleans (U.S.A.)
  8. Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging., Fumiyuki Yamasaki, Kazuhiko Sugiyama, Yoshinori Kajiwara, Taiichi Saito, Toshikazu Hidaka, Takeshi Nishimoto, Yosuke Watanabe, Kaoru Kurisu, 3rd Quadrennial Meeting of the World Federation of Neuro-Oncology, 2009/05/11, Without Invitation, English, WFNO, Yokohama (Japan)
  9. MR spectroscopic detection of lactate is predictive of a poor prognosis in patients with brainstem glioma, Fumiyuki Yamasaki, Yoshinori Kajiwara, Taiichi Saito, Yosuke Watanabe, Kazuhiko Sugiyama, Kaoru Kurisu, 48th Annual Meeting & The Foundation of the ASNR Symposium, 2010/05/18, Without Invitation, English, ASNR, Boston
  10. Advantages of High b-Value Diffusion-Weighted Imaging to Diagnose Pseudo-Response in Patients with Recurrent Glioblastoma after Bevacizumab Treatment: Case Report., Fumiyuki Yamasaki, Yoshinori Kajiwara, Yosuke Watanabe, Kazuhiko Sugiyama, Kaoru Kurisu, 49th Annual Meeting & The Foundation of the ASNR Symposium, 2011/06/06, Without Invitation, English, ASNR, Seattle (U.S.A.)
  11. Lymphomas, glioblastomas and metastatic tumors: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 tesla, Fumiyuki Yamasaki, Yoshinori Kajiwara, Yosuke Watanabe, Takeshi Takayasu, Ryo Nosaka, Kazuhiko Sugiyama, Kaoru Kurisu, 50th Annual Meeting & The Foundation of the ASNR Symposium, 2012/04/23, Without Invitation, English, ASNR, New York (U.S.A.)
  12. The advantage of advanced MR imaging for the diagnosis of germinoma., Fumiyuki Yamasaki, Atushi Tominaga, Yosuke Watanabe, Yasuyuki Kinoshita, Takeshi Takayasu, Satoshi Usui, Ryo Nosaka, Taiichi Saito, Kazuhiko Sugiyama, Kaoru Kurisu, The 42nd Annual Meeting of The Japanese Society of Neuroradiology, 2013/02/15, Without Invitation, English, Japanese Society of Neuroradiology, Kokura (Japan), http://jsnr42.umin.jp
  13. The usefulness of T2 star/ susceptibility-weighted imaging for detection with cavernous angioma after cranial irradiation to treatment with embryonal tumors, Fumiyuki Yamasaki, Yosuke Watanabe, Takeshi Takayasu, Ryo Nosaka, Yuji Akiyama, Taiichi Saito, Kazuhiko Sugiyama, Kaoru Kurisu, 51st Annual Meeting & The Foundation of the ASNR Symposium, 2013/05/20, Without Invitation, Japanese, ASNR, San Diego (U.S.A.)
  14. Anti-emetic effect of granisetron in patients undergoing cranial radiotherapy, Fumiyuki Yamasaki, Yosuke Watanabe, Ryo Nosaka, Masahiro Kenjo, Kazuhiro Nakamura, Takeshi Takayasu, Atsushi Tominaga, Kazuhiko Sugiyama, Kaoru Kurisu, The 55th Annual Meeting of the Japanese Society of Pediatric Hematology and Oncology, 2013/11/30, Without Invitation, English, Japanese Society of Pediatric Hematology and Oncology, Fukuoka (Japan)
  15. The advantages of advanced MRI for the diagnosis of germinoma, Yamasaki F, Sugiyama K, Kinoshita Y, Usui S, Takayasu T, Nosaka R, Tominaga A, Kurisu K, The 4th International CNS Germ Cell Tumor Symposium, 2015/04/13, Without Invitation, English, International CNS Germ Cell Tumor Symposium, Tokyo (Japan)
  16. Development of cavernous angioma after chemotherapy against desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia, Fumiyuki Yamasaki, Takeshi Takayasu, Ryo Nosaka, Atsushi Tominaga, Kazuhiko Sugiyama, Kaoru Kurisu, ASNR 53rd Annual Meeting & The Foundation of the ASNR Symposium 2015, 2015/04/27, Without Invitation, English, American Society of Neuroradiology, Chicago (U.S.A.)
  17. The advantages of advanced MRI for the diagnosis of germinoma., Yamasaki F, Kinoshita Y, Usui S, Takayasu T, Nosaka R, Sugiyama K, Kurisu K, 43rd Japanese Society for Magnetic Resonance in Medicine, 2015/09/10, Without Invitation, English, JSMRM, Tokyo (Japan)
  18. The advantages of advanced MRI for the diagnosis of germinoma., Yamasaki F, Kinoshita Y, Takayasu T, Usui S, Nosaka R, Sugiyama K, Kurisu K, 20TH ANNUAL SOCIETY FOR NEURO-ONCOLOGY, 2015/11/21, Without Invitation, English, Society for Neuro-Oncology, San Antonio (U.S.A.)
  19. Diffusion MRI of brain tumors., Fumiyuki Yamasaki, 24th annual meeting of International Society for Magnetic Resonance in Medicine, 2016/05/07, With Invitation, English, ISMRM, Singapore (Singapore)
  20. The risk of the cerebrovascular disease at the patients with VEGF targeting therapy, Yamasaki F, Takayasu T, Nosaka R, Saito T, Sugiyama K, Kurisu K, 2016 the Japanese Society of Medical Oncology Annual meeting, 2016/07/30, Without Invitation, English, Japanese Society of Medical Oncology, Kobe (Japan)
  21. The usefulness of T2*WI for the detection of cavernous angioma in long-term survivors of childhood embryonal tumors treated by cranial irradiation, Fumiyuki Yamasaki,, Takeshi Takayasu T, Ryo Nosaka, Masahiro Kenjo, Yuji Akiyama, Kazuhiko Sugiyama, Masao Kobayashi, Kaoru Kurisu, The 44th annual meeting of the Japanese Society for Magnetic Resonance in Medicine, 2016/09/10, Without Invitation, English, JSMRM, Omiya (Japan)
  22. Development of cystic malacia after high dose cranial irradiation of pediatric CNS embryonal tumors in long-term follow-up, Yamasaki F, Kolakshyapati M, Takayasu T, Nosaka R, Sugiyama K, Kurisu K, 21ST ANNUAL SCIENTIFIC MEETING OF THE SOCIETY FOR NEURO-ONCOLOGY, 2016/11/17, Without Invitation, English, Society for Neuro-Oncology, Scottsdale (U.S.A.)
  23. High grade glioma and brainstem glioma in pediatric patients, Fumiyuki Yamasaki, The 58th Annual Meeting of the Japanese Society of Pediatric Hematology/ Oncology, 2016/12/15, With Invitation, Japanese, Japanese Society of Pediatric Hematology/ Oncology, Tokyo (Japan)
  24. Proton MR spectroscopy detection of high lipid levels without central necrosis and high intensity on DWI is characteristics of germinoma, Fumiyuki Yamasaki, Yasuyuki Kinoshita, Satoshi Usui, Takeshi Takayasu, Ryo Nosaka, Manish Kolakshyapati, Taiichi Saito, Kazuhiko Sugiyama, Kaoru Kurisu, 25th annual meeting of International Society for Magnetic Resonance in Medicine, 2017/04/26, Without Invitation, English, ISMRM, Honolulu (U.S.A.)
  25. Non-enhancing peritumoral DWI high lesion in Glioblastoma: A novel diagnostic & specific prognostic indicator, Fumiyuki Yamasaki, Manish Kolakshyapati、Vega Karlowee、Takeshi Takayasu、Yuji Akiyama, Kazuhiko Sugiyama, Kaoru Kurisu.   , JSMRM2017, 2017/09/14, Without Invitation, English, JSMRM, Utsunomiya (JAPAN)
  26. Single voxel proton MR spectroscopic detection of high lipid levels and low ADC is characteristics of germinoma, Fumiyuki Yamasaki, Yasuyuki Kinoshita, Takeshi Takayasu, Satoshi Usui, Manish Kolakshyapati, Motoki Takano, Sayuru Tsuyuguchi, Kazuhiko Sugiyama, Kaoru Kurisu, The 14th Meeting of Asian Society for Neuro-Oncology, 2017/10/30, Without Invitation, English
  27. Cystic enlargement during chemotherapy and growing teratoma syndrome in non-germinomatous germ cell tumor, Fumiyuki Yamasaki, Takeshi Takayasu, Yasuyuki Kinoshita, Satoshi Usui, Motoki Takano, Manish Kolakshyapati, Sayuru Miyamura, Kazuhiko Sugiyama, Kaoru Kurisu, 22nd Society for Neuro-Oncology, 2017/11/17, Without Invitation, Japanese, SNO, San Francisco (U.S.A.)
  28. Advanced MR imaging of germinoma, Fumiyuki Yamasaki, Yasuyuki Kinoshita, Takeshi Takayasu, Satoshi Usui, Manish Kolakshyapati, Motoki Takano, Naoto Yamada, Vishwa Jeet Amatya, Yuji Akiyama, Yukio Takeshima, Kazuhiko Sugiyama, Kaoru Kurisu, The 18th ISPNO (International Symposium on Pediatric Neuro-oncology), 2018/07/02, Without Invitation, English, Denver (U.S.A.)
  29. Radiation-induced meningiomas: Experience at the Hiroshima University Hospital and review of the literature, Fumiyuki Yamasaki, Takeshi Takayasu, Motoki Takano, Ushio Yonezawa, Kazuhiko Sugiyama, Kaoru Kurisu, The 19th International Congress of Neuropathology (ICN) 2018, 2018/09/25, With Invitation, English, Tokyo (Japan)
  30. Bevacizumab markedly reduces the size of active cystic part of tumor, Fumiyuki Yamasaki, Motoki Takano, Ushio Yonezawa, Nobuki Imano, Vishwa Jeet Amatya, Yukio Takeshima Yasuhi Nagata, Kaoru Kurisu, Kazuhiko Sugiyama, JSMO 2019, 2019/07/18, Without Invitation, English, JSMO 2019, Kyoto
  31. Growth hormone deficiency and replacement therapy in pediatric and adolescent brain tumor survivors, Fumiyuki Yamasaki, Yasuyuki Kinoshita, Satoshi Okada, Ikuno Nishibuchi, Motoki Takano, Ushio Yonezawa, Akira Taguchi, Nobuki Imano, Yasushi Nagata, Masao Kobayashi, Kaoru Kurisu, Kazuhiko Sugiyama, JSMO 2019, 2019/07/18, Without Invitation, English, JSMO 2019
  32. Effect of bevacizumab against cystic part of brain tumor, Fumiyuki Yamasaki, Motoki Takano, Ushio Yonezawa, Akira Taguchi, Shumpei Onishi, Kazuhiko Sugiyama, Kaoru Kurisu, 24th Society for Neuro-Oncology, 2019/11/22, Without Invitation, English, SNO, Phoenix, AZ
  33. The role of neurosurgeons for brain tumor survivors, Fumiyuki Yamasaki, The 40th Annual Meeting of The Japanese Congress of Neurological Surgeons, 2020/08/10, With Invitation, Japanese

Awards

  1. 2007, Award of KOUJIN Encouragement, Alumni association KOUJIN of Department of Medicine at Hiroshima University, ADC of brain tumors at MR imaging
  2. 2012, Hiroshima Clinical Surgeons Association Award, Hiroshima Prefectural Medical Association, Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
  3. 2014, Award for Research Encouragement of the Japanese society for Hypothalamic and Pituitary Tumors, The Japanese society for Hypothalamic and Pituitary Tumors, Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of sellar and parasellar lesions and pituitary adenomas.
  4. 2014, Excellent poster award, The Japanese Society of Pediatric Hematology/Oncology, Imaging after treatment with new drugs for glioma
  5. 2015, Best Symposium Award of Japanese Society for CNS Computed Imaging, Japan Society for CNS Computed Imaging, MRS detection of high lipid levels for the differential diagnosis between PCNSL and glioma

Social Activities

History as Committee Members

  1. Representative committee, 2013, The Japan Neurosurgical Society
  2. A councilor, 2013, The Japan Society of Brain Tumor Pathology
  3. A councilor, 2015, 2017, Japanese Society for Pediatric Neurosurgery
  4. JCOG Protocol Review Committee, 2012/11, Japan Clinical Oncology Group
  5. JCOG Brain Tumor Study Group, Representative committee, 2015/04, Japan Clinical Oncology Group
  6. JCOG Geriatric Study Committee: GSC, 2014/03, 2016, Japan Clinical Oncology Group
  7. A councilor, 2019/02, The Japanese Society of Neuroradiology
  8. A councilor, 2019/02, The Japanese Society for Hypothalamic and Pituitary tumors
  9. The Japanese Congress of Neurological Surgeons, 2018/05, The Japanese Congress of Neurological Surgeons Executive Committee
  10. A councilor, 2020/06, The Japanese Society of Pediatric Hematology/Oncology
  11. Representative committee, 2020/07, The Japan Stroke Society

History as Peer Reviews of Academic Papers

  1. 2008, Pathobiology, Others, Reviewer, 1
  2. 2012, Neuroradiology, Others, Reviewer, 1
  3. 2013, Neuroradiology, Others, Reviewer, 2
  4. 2013, Brain Tumor Pathology, Others, Reviewer, 1
  5. 2013, Case Reports in Radiology, Editor, Editorial board, 1
  6. 2014, Neurologia medico-chirurgica, Others, Review Board, 2
  7. 2015, American Journal of Neuroradiology, Others, Reviewer, 1
  8. 2015, Child's Nervous System, Others, Reviewer, 3
  9. 2015, Neurologia medico-chirurgica, Others, Review Board, 3
  10. 2015, Case Reports in Radiology, Editor, Editorial board, 1
  11. 2016, Child's Nervous System, Others, Reviewer, 3
  12. 2016, Neurologia medico-chirurgica, Others, Review Board, 2
  13. 2016, Cancer Science, Others, Reviewer, 1
  14. 2016, Japanese Journal of Clinical Oncology, Others, Reviewer, 2
  15. 2016, Journal of Magnetic Resonance Imaging, Others, Reviewer, 1
  16. 2016, Molecular and Clinical Oncology, Others, Reviewer, 1
  17. 2016, Case Reports in Radiology, Editor, Editorial board, 2
  18. 2017, Journal of the Neurological Sciences, Others, Reviewer, 1
  19. 2017, Child's Nervous System, Others, Reviewer, 4
  20. 2017, Oncology Letters, Others, Reviewer, 1
  21. 2017, Neurologia medico-chirurgica, Others, Review Board, 4
  22. 2017, CNS Oncology, Others, Reviewer, 1
  23. 2017, Japanese Journal of Clinical Oncology, Others, Reviewer, 1
  24. 2017, Cancer Biomarkers, Others, Reviewer, 1
  25. 2017, NMR in Biomedicine, Others, Reviewer, 1
  26. 2017, International Journal of Neuroscience, Others, Reviewer, 1
  27. 2017, Neuroradiology, Others, Reviewer, 1
  28. 2018, Child's Nervous System, Others, Reviewer, 6
  29. 2018, Journal of Surgical Case Reports, Others, Reviewer, 1
  30. 2018, Neurologia medico-chirurgica, Others, Review Board, 2
  31. 2018, Neuroradiology, Others, Reviewer, 1
  32. 2018, Case Reports in Radiology, Editor, Editorial board, 1
  33. 2018, Japanese Journal of Neurosurgery, Editor, 3
  34. 2018, Neurosurgery, Others, Reviewer, 1
  35. 2018, 2018 SNO Annual Meeting - Society for Neuro-Oncology, Others, Abstract reviewer, 30
  36. 2019, Child's Nervous System, Others, Reviewer, 5
  37. 2019, Neurosurgery, Others, reviewer, 2
  38. 2019, Case Reports in Radiology, Editor, Editorial board, 1
  39. 2019, Neurologia medico-chirurgica, Others, Review board, 3
  40. 2019, Japanese Journal of Neurosurgery, Editor, Editorial board, 3
  41. 2019, Japanese Journal of Clinical Oncology, Others, Review board, 3
  42. 2019, BMC Cancer, Others, Reviewer, 1
  43. 2019, Journal of Surgical Case Reports, Others, Reviewer, 1
  44. 2019, European Radiology, Others, Reviewer, 3
  45. 2019, 2019 SNO Annual Meeting - Society for Neuro-Oncology, Others, Abstract reviewer, 24
  46. 2020, Japanese Journal of Neurosurgery, Editor, Editorial board, 1
  47. 2020, Nervous System in Children, Others, Reviewer, 1
  48. 2020, Child's Nervous System, Others, Reviewer, 6
  49. 2020, Neurologia medico-chirurgica, Others, Review Board, 3
  50. 2020, International Journal of Clinical Oncology, Others, Reviewer, 3
  51. 2020, Brain Tumor Pathology, Others, Reviewer, 1
  52. 2020, Journal of Surgical Case Reports, Others, Reviewer, 2
  53. 2020, International Journal of Neuroscience, Others, Reviewer, 1